Clinical Trial Update: Tolerability of Grazax in Patients With Hayfever in Real Life Settings [Phase 4]

View source ↗

Summary

Phase 4 trial update on tolerability of Grazax in real-life patients with hay fever.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis

Drugs mentioned

• GRAZAX (birch pollen sublingual immunotherapy tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinoconjunctivitis | Phase 4 | Status: COMPLETED